Annual Total Liabilities
$2.38 B
+$488.04 M+25.84%
December 31, 2024
Summary
- As of March 12, 2025, BBIO annual total liabilities is $2.38 billion, with the most recent change of +$488.04 million (+25.84%) on December 31, 2024.
- During the last 3 years, BBIO annual total liabilities has risen by +$498.58 million (+26.54%).
- BBIO annual total liabilities is now at all-time high.
Performance
BBIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.38 B
+$493.58 M+26.21%
December 31, 2024
Summary
- As of March 12, 2025, BBIO quarterly total liabilities is $2.38 billion, with the most recent change of +$493.58 million (+26.21%) on December 31, 2024.
- Over the past year, BBIO quarterly total liabilities has increased by +$493.58 million (+26.21%).
- BBIO quarterly total liabilities is now at all-time high.
Performance
BBIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BBIO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.8% | +26.2% |
| 3 y3 years | +26.5% | +26.2% |
| 5 y5 years | +1426.6% | +26.2% |
BBIO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.3% | at high | +29.2% |
| 5 y | 5-year | at high | +1426.6% | at high | +1426.6% |
| alltime | all time | at high | +2614.1% | at high | +2614.1% |
BridgeBio Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.38 B(+25.8%) | $2.38 B(+26.2%) |
| Sep 2024 | - | $1.88 B(+0.4%) |
| Jun 2024 | - | $1.88 B(-0.5%) |
| Mar 2024 | - | $1.89 B(-0.1%) |
| Dec 2023 | $1.89 B(+1.1%) | $1.89 B(+2.2%) |
| Sep 2023 | - | $1.85 B(-0.2%) |
| Jun 2023 | - | $1.85 B(+0.8%) |
| Mar 2023 | - | $1.84 B(-1.5%) |
| Dec 2022 | $1.87 B(-0.6%) | $1.87 B(+0.5%) |
| Sep 2022 | - | $1.86 B(-1.0%) |
| Jun 2022 | - | $1.88 B(+1.3%) |
| Mar 2022 | - | $1.85 B(-1.3%) |
| Dec 2021 | $1.88 B | $1.88 B(+23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $1.52 B(-1.3%) |
| Jun 2021 | - | $1.54 B(+3.8%) |
| Mar 2021 | - | $1.48 B(+148.7%) |
| Dec 2020 | $595.70 M(+282.6%) | $595.70 M(+4.6%) |
| Sep 2020 | - | $569.31 M(-1.5%) |
| Jun 2020 | - | $577.72 M(+7.4%) |
| Mar 2020 | - | $537.73 M(+245.4%) |
| Dec 2019 | $155.70 M(+77.8%) | $155.70 M(+33.9%) |
| Sep 2019 | - | $116.26 M(-80.4%) |
| Jun 2019 | - | $593.09 M(+553.8%) |
| Mar 2019 | - | $90.71 M(+3.6%) |
| Dec 2018 | $87.58 M(-42.7%) | $87.58 M |
| Dec 2017 | $152.73 M | - |
FAQ
- What is BridgeBio Pharma annual total liabilities?
- What is the all time high annual total liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma annual total liabilities year-on-year change?
- What is BridgeBio Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly total liabilities year-on-year change?
What is BridgeBio Pharma annual total liabilities?
The current annual total liabilities of BBIO is $2.38 B
What is the all time high annual total liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total liabilities is $2.38 B
What is BridgeBio Pharma annual total liabilities year-on-year change?
Over the past year, BBIO annual total liabilities has changed by +$488.04 M (+25.84%)
What is BridgeBio Pharma quarterly total liabilities?
The current quarterly total liabilities of BBIO is $2.38 B
What is the all time high quarterly total liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total liabilities is $2.38 B
What is BridgeBio Pharma quarterly total liabilities year-on-year change?
Over the past year, BBIO quarterly total liabilities has changed by +$493.58 M (+26.21%)